Return to homepagePandemic Pact

A phase 2/3, observer-blind, randomized, controlled Study to determine the safety and immunogenicity of Covishield (covid-19 vaccine) in healthy Indian adults

  • Funded by Indian Council of Medical Research (ICMR), University of Oxford
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $100,000

  • Funder

    Indian Council of Medical Research (ICMR), University of Oxford

  • Principal Investigator

    Dr. Padmapriya

  • Research Location

    India

  • Lead Research Institution

    ICMR-National Institute for Research in Tuberculosis (NIRT)

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 2 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase II

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract